Additionally, in the hypoxic tumor microenvironment, HIF-1α and HIF-2α stabilize and interact with co-activators to preferentially drive the expression of VEGF, CXCL12, and other genes that skew macrophages toward an immunosuppressive M2-like state. The gene discussed is CXCL12; the disease is neoplasm.